Drug Development Drug Interactions Drug Effects Medications Drug Safety Antibiotics Pain Management Drugs Drug Mechanisms Weight Loss Drugs
Two remaining Phase 3 studies in atrial fibrillation and secondary stroke prevention continue, with topline results expected in 2026.